Related Experiment Video
Updated: Jun 25, 2025

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
Published on: July 3, 2013
UKLF/PCBP2 axis governs the colorectal cancer development by transcriptionally activating SLC39A4
1Department of General Surgery, Shengjing Hospital of China Medical University, 36 Sanhao Street, Shenyang 110004, China.
Abstract:
Colorectal cancer (CRC) is one of the most prevalent malignant tumors with limited treatment options. Therefore, there is an urgent need to investigate new therapeutic targets against CRC. Ubiquitous Kruppel-like factor (UKLF) is involved in various cancer processes, but its effect and detailed molecular mechanism in CRC are not yet fully understood. Here, this study aimed to investigate the function and mechanism of UKLF in the development of CRC. The results showed that UKLF was highly expressed in CRC tissues from clinical patients and its high expression was related to poor prognosis. UKLF promoted cell proliferation, migration and invasion, and inhibited cell apoptosis. The promotion effect of UKLF on tumor growth was further confirmed in vivo. As far as the mechanism was concerned, poly (C) binding protein 2 (PCBP2) was verified to bind to the 3'-UTR of UKLF mRNA and enhance its mRNA stability. Moreover, UKLF modulated the expression of solute carrier family 39 member 4 (SLC39A4) at the transcriptional level. Taken together, these findings elucidated the regulatory mechanism of UKLF and uncovered the importance of the PCBP2/UKLF/SLC39A4 pathway. The targeting of UKLF may be a novel direction for molecular-targeted CRC therapy.
Insights
Ubiquitous Kruppel-like factor (UKLF) drives colorectal cancer (CRC) growth and spread. Targeting the PCBP2/UKLF/SLC39A4 pathway offers a potential new strategy for CRC treatment.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Colorectal cancer (CRC) presents significant treatment challenges.
- New therapeutic targets for CRC are urgently needed.
- The role of Ubiquitous Kruppel-like factor (UKLF) in CRC is not fully understood.
Purpose of the Study:
- To investigate the function and molecular mechanism of UKLF in colorectal cancer development.
- To explore the potential of UKLF as a therapeutic target for CRC.
Main Methods:
- Analysis of UKLF expression in clinical CRC tissues.
- In vitro assays assessing cell proliferation, migration, invasion, and apoptosis.
- In vivo tumor growth studies.
- Investigation of regulatory mechanisms involving PCBP2 and SLC39A4.
Main Results:
- UKLF was highly expressed in CRC tissues and correlated with poor prognosis.
- UKLF promoted CRC cell proliferation, migration, and invasion while inhibiting apoptosis.
- UKLF accelerated tumor growth in vivo.
- PCBP2 enhances UKLF mRNA stability by binding to its 3'-UTR.
- UKLF regulates SLC39A4 expression transcriptionally.
Conclusions:
- UKLF plays a critical role in promoting CRC progression.
- The PCBP2/UKLF/SLC39A4 pathway is crucial in CRC development.
- Targeting UKLF represents a promising novel therapeutic strategy for colorectal cancer.
Related Concept Videos
Pleiotropy
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Renewal of Intestinal Stem Cells
Non-LTR Retrotransposons
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

